Clinical Trial Update: Drug-drug Interaction Study of Eltrombopag and Cyclosporine in Healthy Subjects [Phase 1]

View source ↗

Summary

A Phase 1 study assessing the drug-drug interaction between eltrombopag and cyclosporine in healthy subjects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• Eltrombopag (eltrombopag)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Purpura, Thrombocytopenic, Idiopathic | Phase 1 | Status: COMPLETED